Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

  • Quoted phrase not found.
1.

Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.

Butrick M, Kelly S, Peshkin BN, Luta G, Nusbaum R, Hooker GW, Graves K, Feeley L, Isaacs C, Valdimarsdottir HB, Jandorf L, DeMarco T, Wood M, McKinnon W, Garber J, McCormick SR, Schwartz MD.

Genet Med. 2015 Jun;17(6):467-75. doi: 10.1038/gim.2014.125. Epub 2014 Sep 18.

2.

The actual scenario of neoadjuvant chemotherapy of breast cancer in developing country: a report of 80 cases of breast cancer from a tertiary cancer center in India.

Das U, Lakshmaiah KC, Govind Babu K, Suresh TM, Lokanatha D, Jacob L, Babu S.

J Cancer Res Clin Oncol. 2014 Oct;140(10):1777-82. doi: 10.1007/s00432-014-1724-1. Epub 2014 Jun 4.

PMID:
24894013
3.

Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study.

Kurta ML, Moysich KB, Weissfeld JL, Youk AO, Bunker CH, Edwards RP, Modugno F, Ness RB, Diergaarde B.

Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1282-92. doi: 10.1158/1055-9965.EPI-12-0426. Epub 2012 Jun 15.

4.

Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer.

Barlin JN, Yu C, Hill EK, Zivanovic O, Kolev V, Levine DA, Sonoda Y, Abu-Rustum NR, Huh J, Barakat RR, Kattan MW, Chi DS.

Gynecol Oncol. 2012 Apr;125(1):25-30. doi: 10.1016/j.ygyno.2011.12.423. Epub 2011 Dec 9.

PMID:
22155261
5.

The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations.

Gray SW, Hornik RC, Schwartz JS, Armstrong K.

Clin Genet. 2012 Jan;81(1):29-37. doi: 10.1111/j.1399-0004.2011.01797.x. Epub 2011 Nov 2.

6.

Permanence of the information given during oncogenetic counseling to persons at familial risk of breast/ovarian and/or colon cancer.

Kwiatkowski F, Dessenne P, Laquet C, Petit MF, Bignon YJ.

Eur J Hum Genet. 2012 Feb;20(2):141-7. doi: 10.1038/ejhg.2011.169. Epub 2011 Sep 21.

7.

Oral contraceptive use in women at increased risk of breast/ovarian cancer: knowledge and attitudes.

Bui KT, Wakefield CE, Kasparian NA, Tyler J, Abbott J, Tucker K.

Psychooncology. 2013 Jan;22(1):228-32. doi: 10.1002/pon.2049. Epub 2011 Sep 9.

PMID:
21905159
8.
9.

Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families.

Duffy DL, Antill YC, Stewart CJ, Young JP; kConFab., Spurdle AB.

Twin Res Hum Genet. 2011 Apr;14(2):111-8. doi: 10.1375/twin.14.2.111.

PMID:
21425892
10.

Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers.

Kenkhuis MJ, de Bock GH, Elferink PO, Arts HJ, Oosterwijk JC, Jansen L, Mourits MJ.

Maturitas. 2010 Jul;66(3):310-4. doi: 10.1016/j.maturitas.2010.03.018. Epub 2010 Apr 21.

PMID:
20409655
11.

Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.

Gray SW, O'Grady C, Karp L, Smith D, Schwartz JS, Hornik RC, Armstrong K.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1303-11. doi: 10.1158/1055-9965.EPI-08-0825. Epub 2009 Mar 24.

12.

Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations.

Gates MA, Tworoger SS, Terry KL, De Vivo I, Hunter DJ, Hankinson SE, Cramer DW.

Int J Cancer. 2009 Feb 1;124(3):729-33. doi: 10.1002/ijc.23924.

13.

Genetic services for hereditary breast/ovarian and colorectal cancers - physicians' awareness, use and satisfaction.

Carroll JC, Cappelli M, Miller F, Wilson BJ, Grunfeld E, Peeters C, Hunter AG, Gilpin C, Prakash P.

Community Genet. 2008;11(1):43-51. doi: 10.1159/000111639. Epub 2008 Jan 15.

PMID:
18196917
14.
15.

A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk.

Wakefield CE, Meiser B, Homewood J, Peate M, Taylor A, Lobb E, Kirk J, Young MA, Williams R, Dudding T, Tucker K; AGenDA Collaborative Group..

Breast Cancer Res Treat. 2008 Jan;107(2):289-301. Epub 2007 Feb 27.

PMID:
17333332
16.

Facilitating informed decision making about breast cancer risk and genetic counseling among women calling the NCI's Cancer Information Service.

Miller SM, Fleisher L, Roussi P, Buzaglo JS, Schnoll R, Slater E, Raysor S, Popa-Mabe M.

J Health Commun. 2005;10 Suppl 1:119-36.

PMID:
16377604
17.

Estimated prevalence of hereditary cancers and the need for surveillance in a Norwegian county, Telemark.

Stormorken AT, Hoff G, Norstein J, Bowitz-Lothe IM, Hanslien E, Grindedal E, Møller P.

Scand J Gastroenterol. 2006 Jan;41(1):71-9.

PMID:
16373279
18.

Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.

Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L, Freedman AN.

J Med Genet. 2005 Oct;42(10):749-55. Epub 2005 Mar 22.

19.

Acetyl-CoA carboxylase alpha gene and breast cancer susceptibility.

Sinilnikova OM, Ginolhac SM, Magnard C, Léoné M, Anczukow O, Hughes D, Moreau K, Thompson D, Coutanson C, Hall J, Romestaing P, Gérard JP, Bonadona V, Lasset C, Goldgar DE, Joulin V, Venezia ND, Lenoir GM.

Carcinogenesis. 2004 Dec;25(12):2417-24. Epub 2004 Aug 27.

PMID:
15333468
20.

Impact of genetic testing for breast-ovarian cancer susceptibility.

Loader S, Shields CG, Rowley PT.

Genet Test. 2004 Spring;8(1):1-12.

PMID:
15140369

Supplemental Content

Loading ...
Support Center